Skip to main content
Clinical Trials/NCT04027777
NCT04027777
Recruiting
Not Applicable

Single-center Prospective Observational Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation

Aktiia SA2 sites in 1 country355 target enrollmentStarted: August 6, 2019Last updated:
ConditionsBlood Pressure
InterventionsAktiia.product-P0

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Aktiia SA
Enrollment
355
Locations
2
Primary Endpoint
Blood Pressure absolute Mean Error

Overview

Brief Summary

Single-centre prospective observational study to validate the performance of the Aktiia SA optical blood pressure monitoring (OBPM) device at the wrist against blood pressure measurements obtained by double auscultation at the upper arm during four weeks

Detailed Description

According to the World Health Organization, by 2025 hypertension will affect 1.5 billion adults worldwide. Half of the adult population is not diagnosed, and half of the treated population is not at the defined target of BP. Widespread use of out of office BP measurement is one of the proposed strategies to fight against hypertension worldwide.

The current Ambulatory Blood Pressure Monitoring or Home Blood Pressure Monitoring are performed with a cuff placed around the arm. This 110-year-old technology is not only uncomfortable for the patient but can also result in a number of overestimated readings due to the stress induced while inflating the cuff.

Aktiia S.A. has developed an intermittent automated non-invasive cuffless blood pressure monitor determining over a series of cardiac cycles the values of the systolic blood pressure, the diastolic blood pressure and the heart rate. This miniature device is comfortably positioned with a bracelet on a user's wrist. The optical sensors integrated within the device exploit the principle of reflection photoplethysmography (PPG) to capture the user's skin pulsatility (change of arterial diameter occurring at each heartbeat). Aktiia OBPM algorithms are further applied to the recorded PPG signal to determine user's blood pressure and heart rate.

Because the measurement relies on optical sensors, and not on pneumatic cuffs, Aktiia OBPM device provides an increased overall comfort to the patient throughout the monitoring, does not induce sleep arousal during the night measurements and decreases the false positive readings induced by the stress associated with the cuff inflation. Aktiia OBPM device is intended to be used in the long term, as compared to one-day or one-week use of Ambulatory Blood Pressure Monitors.

This study over several visits has been designed to assess both the accuracy and the stability of the Aktiia OBPM. The automaticity of the measurement when performed in different body positions and upon aerobic exercise was also evaluated.

By demonstrating both the accuracy and the stability of the measurements that can be performed in different body positions with a comfortable and miniature Aktiia OBPM device, Aktiia SA aims to make one step further in facilitating blood pressure measurement and monitoring in the out-of-clinic scenarios and integrating blood pressure monitoring into user's daily life. The diagnosis and treatment of hypertension in ambulatory settings is expected to largely benefit from these advancements

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
21 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Inclusion Criteria:
  • Adult subjects (aged between 21 and 65 years old)
  • Subjects fluent in written and spoken French
  • Subjects agreeing to attend the totality of 4 visits
  • Subjects that have signed the informed consent form

Exclusion Criteria

  • Subjects with tachycardia (heart rate at rest \> 120bpm)
  • Subjects with atrial fibrillation
  • Subjects with diabetes
  • Subjects with renal dysfunctions (eGFR \< 60mL/min/1.73 m2)
  • Subjects with hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Subjects with Raynaud's disease
  • Subjects with trembling and shivering
  • Subjects with interarm systolic difference \> 15 mmHg
  • Subjects with interarm diastolic difference \> 10 mmHg

Arms & Interventions

Aktiia.product-P0 and subjects with Chronic Kidney disease

Experimental

Additional study arm including 40 subjects with chronic kidney disease (ARM 4)

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0

Experimental

Main study arm including 105 subjects

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0 Diabetics

Experimental

Second study arm including 40 diabetic patients

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0 Aged

Experimental

Thirs study arm including 40 patients aged 65+

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0 and subjects with Heart Failure

Experimental

Additional study arm including 40 subjects with Heart Failure (ARM 5)

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0 and Pregnant subjects

Experimental

Additional study arm including 50 pregnant subjects (ARM 6)

Intervention: Aktiia.product-P0 (Device)

Aktiia.product-P0 and subjects in Post partum

Experimental

Additional study arm including 40 subjects in post partum (ARM 7)

Intervention: Aktiia.product-P0 (Device)

Outcomes

Primary Outcomes

Blood Pressure absolute Mean Error

Time Frame: Up to four weeks

The absolute value of the mean of the differences between Reference and Aktiia.product-P0 blood pressure determinations

Blood Pressure standard Deviation of the Error

Time Frame: Up to four weeks

The standard deviation of the differences between Reference and Aktiia.product-P0 determinations

Secondary Outcomes

  • Heart Rate root-mean-square error(Up to four weeks)

Investigators

Sponsor
Aktiia SA
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials